Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Rodriguez

Showing results (351-360 of 437) with videos related to

Pageof 44
Sort By:
Genes & Diseases|January 16, 2026
Corrigendum to 'Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy' [Genes Dis (12) (2025) 101609]Francisco Javier Rodriguez-Jimenez, Ana Artero-Castro, Hana Studenovska, et al.
Nature Communications|January 15, 2025
Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, et al.
Stem Cells Translational Medicine|February 19, 2017
Highly Efficient Neural Conversion of Human Pluripotent Stem Cells in Adherent and Animal-Free ConditionsDunja Lukovic, Andrea Diez Lloret, Petra Stojkovic, et al.
International Journal of Cardiology|March 8, 2024
Diameter and dissection of the abdominal aorta and the risk of distal aortic reoperation after surgery for type A aortic dissectionFausto Biancari, Andrea Perrotti, Tatu Juvonen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistanceShuijie Li, Javier Rodriguez, Wenyu Li, et al.
Nature Communications|June 7, 2023
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancerTakayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav, et al.
Journal for Immunotherapy of Cancer|October 1, 2018
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasisJavier Rodriguez, Eduardo Castañón, Jose Luis Perez-Gracia, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2013
Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancerSusana B Bravo, Maria E R Garcia-Rendueles, Angela R Garcia-Rendueles, et al.
Pediatrics|March 29, 2024
Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children <5 Years of AgeTrisha Dalapati, Caitlin A Williams, Elena E Giorgi, et al.
Biomedicines|April 23, 2022
Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?Verónica Pulito-Cueto, Sara Remuzgo-Martínez, Fernanda Genre, et al.
Pageof 44

Showing results (351-360 of 437) with videos related to

Sort By:
Pageof 44
Genes & Diseases|January 16, 2026
Corrigendum to 'Restored phagocytic ability of RPE patches derived from gene-corrected retinitis pigmentosa-hiPSCs on a biodegradable scaffold via clinical-grade protocol: Implications for autologous therapy' [Genes Dis (12) (2025) 101609]Francisco Javier Rodriguez-Jimenez, Ana Artero-Castro, Hana Studenovska, et al.
Nature Communications|January 15, 2025
Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, et al.
Stem Cells Translational Medicine|February 19, 2017
Highly Efficient Neural Conversion of Human Pluripotent Stem Cells in Adherent and Animal-Free ConditionsDunja Lukovic, Andrea Diez Lloret, Petra Stojkovic, et al.
International Journal of Cardiology|March 8, 2024
Diameter and dissection of the abdominal aorta and the risk of distal aortic reoperation after surgery for type A aortic dissectionFausto Biancari, Andrea Perrotti, Tatu Juvonen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistanceShuijie Li, Javier Rodriguez, Wenyu Li, et al.
Nature Communications|June 7, 2023
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancerTakayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav, et al.
Journal for Immunotherapy of Cancer|October 1, 2018
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasisJavier Rodriguez, Eduardo Castañón, Jose Luis Perez-Gracia, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2013
Humanized medium (h7H) allows long-term primary follicular thyroid cultures from human normal thyroid, benign neoplasm, and cancerSusana B Bravo, Maria E R Garcia-Rendueles, Angela R Garcia-Rendueles, et al.
Pediatrics|March 29, 2024
Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children <5 Years of AgeTrisha Dalapati, Caitlin A Williams, Elena E Giorgi, et al.
Biomedicines|April 23, 2022
Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?Verónica Pulito-Cueto, Sara Remuzgo-Martínez, Fernanda Genre, et al.
Pageof 44